Elevated mercury levels linked with higher prevalence of non-melanoma skin cancer

Elevated mercury levels linked with higher prevalence of non-melanoma skin cancer

Higher levels of mercury in the blood were linked with a higher prevalence of non-melanoma skin cancer, the most common human malignancy, in a study published in the British Journal of Dermatology . For the study, researchers analyzed 2003-2016 data on 29,413 participants in the National Health and Nutrition Examination Survey. The team examined blood levels of different forms of mercury: total mercury, inorganic mercury, and methyl mercury. Compared with individuals with low total mercury, those with high total mercury had nearly double the odds of being diagnosed with non-melanoma skin cancer. Similarly, participants with high methyl mercury had a 1.7-times greater odds of non-melanoma skin cancer compared with those with low methyl mercury. Inorganic mercury levels were non-significantly but positively associated with non-melanoma skin cancer. Most individuals in the United States are exposed to mercury through consumption of contaminated fish and shellfish. Source: Wiley Journal reference: Rhee, J., et al. (2020) Association of blood mercury levels with nonmelanoma skin cancer in the U.S.A. using National Health and Nutrition Examination Survey data (2003–2016). British Journal of Dermatology. doi.org/10.1111/bjd.18797 .



Also in Industry News

How to decide whether or not to start treatment for prostate cancer?
How to decide whether or not to start treatment for prostate cancer?

0 Comments

How to decide whether or not to start treatment for prostate cancer?

Read More

Analysis of the SARS-CoV-2 proteome via visual tools
Analysis of the SARS-CoV-2 proteome via visual tools

0 Comments

Analysis of the SARS-CoV-2 proteome via visual tools

Read More

$65m investment increases British Patient Capital’s exposure to life sciences and health technology
$65m investment increases British Patient Capital’s exposure to life sciences and health technology

0 Comments

$65m investment increases British Patient Capital’s exposure to life sciences and health technology

Read More